Dr. Joaquim Bellmunt describes the study examining adjuvant atezolizumab in bladder cancer, as well as adjuvant nivolumab and ctDNA in bladder cancer.
Dr. Joaquim Bellmunt describes the study examining adjuvant atezolizumab in bladder cancer, as well as adjuvant nivolumab and ctDNA in bladder cancer.